Atrys Health, S.A. (BME:ATRY)

Market Cap	222.78M +4.8%
Revenue (ttm)	144.31M -33.8%
Net Income	-100.30M
EPS	-1.32
Shares Out	75.91M
PE Ratio	n/a
Forward PE	50.76
Dividend	n/a
Ex-Dividend Date	n/a

Volume	38,975
Average Volume	88,408
Open	2.945
Previous Close	2.935
Day's Range	2.900 - 2.945
52-Week Range	2.480 - 3.590
Beta	0.56
RSI	51.07
Earnings Date	Jun 22, 2026

About Atrys Health

Atrys Health, S.A., together with its subsidiaries, provides diagnostic services and medical treatments in Spain, Portugal, and Latin America. It operates through Diagnosis, Oncology, and Preventive Medicine segments. The company offers integrated diagnostics services comprising structural and molecular pathology, genetics, and nuclear medicine diagnosis; online medical imaging in the fields of radiology and cardiology; oncology treatment services, such as chemotherapy, immunotherapy, radiotherapy, and brachytherapy; second opinion and genetic ...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2007
• Employees: 1,985
• Stock Exchange: Madrid Stock Exchange
• Ticker Symbol: ATRY

Financial Performance

In 2025, Atrys Health's revenue was 144.31 million, a decrease of -33.83% compared to the previous year's 218.10 million. Losses were -100.30 million, 215.7% more than in 2024.